Skip to main content
Livermore
Livermore
ZHEN

Qube Research & Technologies Ltd

SEC CIK
0001729829
Latest filing
Aug 14, 2026

COLL holding history

Collegium Pharmaceutical, Inc in every 13F filed by Qube Research & Technologies Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

COLL overviewAll 13F holders of COLLFull Q2 2026 holdings

Shares (Q2 2026)
431,447
Value
$15.6M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of COLL by Qube Research & Technologies Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026431,447$15.6M<0.1%−190,488−30.6%ReducedHolders
Q1 2026621,935$20.6M<0.1%+353,693+131.9%AddedHolders
Q4 2025268,242$12.4M<0.1%−52,317−16.3%ReducedHolders
Q3 2025320,559$11.2M<0.1%+225,679+237.9%AddedHolders
Q2 202594,880$2.81M<0.1%+41,315+77.1%AddedHolders
Q1 202553,565$1.60M<0.1%−164,248−75.4%ReducedHolders
Q4 2024217,813$6.24M<0.1%+149,666+219.6%AddedHolders
Q3 202468,147$2.63M<0.1%+13,691+25.1%AddedHolders
Q2 202454,456$1.75M<0.1%+54,456NewHolders
Q1 20240$00.0%−16,001−100.0%Sold outHolders
Q4 202316,001$492.5K<0.1%−111,009−87.4%ReducedHolders
Q3 2023127,010$2.84M<0.1%+111,394+713.3%AddedHolders
Q2 202315,616$335.6K<0.1%−19,348−55.3%ReducedHolders
Q1 202334,964$838.8K<0.1%+34,964NewHolders
Q2 20220$00.0%−19,699−100.0%Sold outHolders
Q1 202219,699$401.0K<0.1%−62,177−75.9%ReducedHolders
Q4 202181,876$1.53M<0.1%+55,581+211.4%AddedHolders
Q3 202126,295$519.0K<0.1%+8,280+46.0%AddedHolders
Q2 202118,015$426.0K<0.1%−1,844−9.3%ReducedHolders
Q1 202119,859$471.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.